The functional role of platelets in the regulation of angiogenesis

References

• Shattil SJ, Newman PJ. Integrins: Dynamic scaffolds for adhesion and signaling in platelets. Blood 2004;104:1606–1615
   PubMed Web of Science ®Google Scholar
• Andrews RK, Gardiner EE, Shen Y, Berndt MC. Platelet interactions in thrombosis. IUBMB Life 2004;56:13–18
   PubMedGoogle Scholar
• Bizzozero. Su di un nuovo elemento morfologico del sangue dei mammiferi e sulla sua importanza nella trombosi e nella coagulazione. Osservatore Gazetta delle Cliniche 1881;17:785–787
   Google Scholar
• Brewer DB. Max Schultze (1865), G. Bizzozero (1882) and the discovery of the platelet. Br J Haematol 2006;133:251–258
   PubMedGoogle Scholar
• Sun NC, McAfee WM, Hum GJ, Weiner JM. Hemostatic abnormalities in malignancy, a prospective study of one hundred eight patients. Part I. Coagulation studies. Am J Clin Pathol 1979;71:10–16
   PubMed Web of Science ®Google Scholar
• Tesselaar ME, Romijn FP, Van Der Linden IK, Prins FA, Bertina RM, Osanto S. Microparticle-associated tissue factor activity: A link between cancer and thrombosis? J Thromb Haemost 2007;5:520–527
   PubMed Web of Science ®Google Scholar
• Pinedo HM, Verheul HM, D'Amato RJ, Folkman J. Involvement of platelets in tumour angiogenesis? Lancet 1998;352:1775–1777
   PubMed Web of Science ®Google Scholar
• Pipili-Synetos E, Papadimitriou E, Maragoudakis ME. Evidence that platelets promote tube formation by endothelial cells on matrigel. Br J Pharmacol 1998;125:1252–1257
   PubMed Web of Science ®Google Scholar
• Andrews RK, Berndt MC. Platelet physiology and thrombosis. Thromb Res 2004;114:447–453
   PubMed Web of Science ®Google Scholar
• Nieswandt B, Watson SP. Platelet-collagen interaction: Is GPVI the central receptor? Blood 2003;102:449–461
   PubMed Web of Science ®Google Scholar
• Ruggeri ZM, Mendolicchio GL. Adhesion mechanisms in platelet function. Circ Res 2007;100:1673–1685
   PubMed Web of Science ®Google Scholar
• De Meyer SF, Deckmyn H, Vanhoorelbeke K. von Willebrand factor to the rescue. Blood 2009;113:5049–5057
   PubMed Web of Science ®Google Scholar
• Gardiner EE, Arthur JF, Shen Y, Karunakaran D, Moore LA, Am Esch JS, 2nd, Andrews RK, Berndt MC. GPIbalpha-selective activation of platelets induces platelet signaling events comparable to GPVI activation events. Platelets 2010;21:244–252
   PubMed Web of Science ®Google Scholar
• Ruggeri ZM. Structure and function of von Willebrand factor. Thromb Haemost 1999;82:576–584
   PubMed Web of Science ®Google Scholar
• Andrews RK, Gardiner EE, Shen Y, Whisstock JC, Berndt MC. Glycoprotein Ib-IX-V. Int J Biochem Cell Biol 2003;35:1170–1174
   PubMed Web of Science ®Google Scholar
• Lopez JA, Andrews RK, Afshar-Kharghan V, Berndt MC. Bernard–Soulier syndrome. Blood 1998;91:4397–4418
   PubMed Web of Science ®Google Scholar
• Fredrickson BJ, Dong JF, McIntire LV, Lopez JA. Shear-dependent rolling on von Willebrand factor of mammalian cells expressing the platelet glycoprotein Ib-IX-V complex. Blood 1998;92:3684–3693
   PubMed Web of Science ®Google Scholar
• Farndale RW, Sixma JJ, Barnes MJ, de Groot PG. The role of collagen in thrombosis and hemostasis. J Thromb Haemost 2004;2:561–573
   PubMed Web of Science ®Google Scholar
• Kato K, Kanaji T, Russell S, Kunicki TJ, Furihata K, Kanaji S, Marchese P, Reininger A, Ruggeri ZM, Ware J. The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion. Blood 2003;102:1701–1707
   PubMed Web of Science ®Google Scholar
• Massberg S, Gawaz M, Gruner S, Schulte V, Konrad I, Zohlnhofer D, Heinzmann U, Nieswandt B. A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo. J Exp Med 2003;197:41–49
   PubMed Web of Science ®Google Scholar
• Nieswandt B, Brakebusch C, Bergmeier W, Schulte V, Bouvard D, Mokhtari-Nejad R, Lindhout T, Heemskerk JW, Zirngibl H, Fässler R. Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen. Embo J 2001;20:2120–2130
   PubMed Web of Science ®Google Scholar
• Li Z, Zhang G, Le Breton GC, Gao X, Malik AB, Du X. Two waves of platelet secretion induced by thromboxane A2 receptor and a critical role for phosphoinositide 3-kinases. J Biol Chem 2003;278:30725–30731
   PubMed Web of Science ®Google Scholar
• Gachet C. ADP receptors of platelets and their inhibition. Thromb Haemost 2001;86:222–232
   PubMed Web of Science ®Google Scholar
• Broos K, Feys HB, De Meyer SF, Vanhoorelbeke K, Deckmyn H. Platelets at work in primary hemostasis. Blood Rev 2011;25:155–167
   PubMed Web of Science ®Google Scholar
• Monroe DM, Hoffman M, Roberts HR. Platelets and thrombin generation. Arterioscler Thromb Vasc Biol 2002;22:1381–1389
   PubMed Web of Science ®Google Scholar
• Carmeliet P. Angiogenesis in life, disease and medicine. Nature 2005;438:932–936
   PubMed Web of Science ®Google Scholar
• Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249–257
   PubMed Web of Science ®Google Scholar
• Folkman J. Angiogenesis: An organizing principle for drug discovery? Nat Rev Drug Discov 2007;6:273–286
   PubMed Web of Science ®Google Scholar
• Carmeliet P. Angiogenesis in health and disease. Nat Med 2003;9:653–660
   PubMed Web of Science ®Google Scholar
• Kisucka J, Butterfield CE, Duda DG, Eichenberger SC, Saffaripour S, Ware J, Ruggeri ZM, Jain RK, Folkman J, Wagner DD. Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage. Proc Natl Acad Sci USA 2006;103:855–860
   PubMed Web of Science ®Google Scholar
• Brill A, Elinav H, Varon D. Differential role of platelet granular mediators in angiogenesis. Cardiovasc Res 2004;63:226–235
   PubMed Web of Science ®Google Scholar
• Frojmovic MM, Milton JG. Human platelet size, shape, and related functions in health and disease. Physiol Rev 1982;62:185–261
   PubMed Web of Science ®Google Scholar
• Klement GL, Yip TT, Cassiola F, Kikuchi L, Cervi D, Podust V, Italiano JE, Wheatley E, Abou-Slaybi A, Bender E, et al. Platelets actively sequester angiogenesis regulators. Blood 2009;113:2835–2842
   PubMed Web of Science ®Google Scholar
• Blair P, Flaumenhaft R. Platelet alpha-granules: Basic biology and clinical correlates. Blood Rev 2009;23:177–189
   PubMed Web of Science ®Google Scholar
• Diacovo TG, Puri KD, Warnock RA, Springer TA, von Andrian UH. Platelet-mediated lymphocyte delivery to high endothelial venules. Science 1996;273:252–255
   PubMed Web of Science ®Google Scholar
• Huo Y, Schober A, Forlow SB, Smith DF, Hyman MC, Jung S, Littman DR, Weber C, Ley K. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 2003;9:61–67
   PubMed Web of Science ®Google Scholar
• Moulin V, Lawny F, Barritault D, Caruelle JP. Platelet releasate treatment improves skin healing in diabetic rats through endogenous growth factor secretion. Cell Mol Biol (Noisy-le-grand) 1998;44:961–971
   PubMedGoogle Scholar
• Kaplan DR, Chao FC, Stiles CD, Antoniades HN, Scher CD. Platelet alpha granules contain a growth factor for fibroblasts. Blood 1979;53:1043–1052
   PubMed Web of Science ®Google Scholar
• Wartiovaara U, Salven P, Mikkola H, Lassila R, Kaukonen J, Joukov V, Orpana A, Ristimäki A, Heikinheimo M, Joensuu H, et al. Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation. Thromb Haemost 1998;80:171–175
   PubMed Web of Science ®Google Scholar
• Ben-Ezra J, Sheibani K, Hwang DL, Lev-Ran A. Megakaryocyte synthesis is the source of epidermal growth factor in human platelets. Am J Pathol 1990;137:755–759
   PubMed Web of Science ®Google Scholar
• Browder T, Folkman J, Pirie-Shepherd S. The hemostatic system as a regulator of angiogenesis. J Biol Chem 2000;275:1521–1524
   PubMed Web of Science ®Google Scholar
• Karey KP, Sirbasku DA. Human platelet-derived mitogens. II. Subcellular localization of insulinlike growth factor I to the alpha-granule and release in response to thrombin. Blood 1989;74:1093–1100
   PubMed Web of Science ®Google Scholar
• Gale NW, Yancopoulos GD. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev 1999;13:1055–1066
   PubMed Web of Science ®Google Scholar
• Weltermann A, Wolzt M, Petersmann K, Czerni C, Graselli U, Lechner K, Kyrle PA. Large amounts of vascular endothelial growth factor at the site of hemostatic plug formation in vivo. Arterioscler Thromb Vasc Biol 1999;19:1757–1760
   PubMed Web of Science ®Google Scholar
• Etulain J, Fondevila C, Negrotto S, Schattner M. Platelet-mediated angiogenesis is independent of VEGF and fully inhibited by aspirin. Br J Pharmacol 2013;170:255–265
   PubMed Web of Science ®Google Scholar
• Jimenez B, Volpert OV, Crawford SE, Febbraio M, Silverstein RL, Bouck N. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat Med 2000;6:41–48
   PubMed Web of Science ®Google Scholar
• Kopp HG, Hooper AT, Broekman MJ, Avecilla ST, Petit I, Luo M, Milde T, Ramos CA, Zhang F, Kopp T, et al. Thrombospondins deployed by thrombopoietic cells determine angiogenic switch and extent of revascularization. J Clin Invest 2006;116:3277–3291
   PubMedGoogle Scholar
• Feng W, Madajka M, Kerr BA, Mahabeleshwar GH, Whiteheart SW, Byzova TV. A novel role for platelet secretion in angiogenesis: Mediating bone marrow-derived cell mobilization and homing. Blood 2011;117:3893–3902
   PubMed Web of Science ®Google Scholar
• Huang Z, Rahman MF, Jiang L, Xie H, Hu H, Lui WO, Li N. Thrombin induces de novo protein synthesis of SDF-1alpha but not angiostatin in human platelets. J Thromb Haemost 2012;10:2202–2205
   PubMedGoogle Scholar
• Maione TE, Gray GS, Petro J, Hunt AJ, Donner AL, Bauer SI, Carson HF, Sharpe RJ. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 1990;247:77–79
   PubMed Web of Science ®Google Scholar
• Date K, Matsumoto K, Kuba K, Shimura H, Tanaka M, Nakamura T. Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor. Oncogene 1998;17:3045–3054
   PubMed Web of Science ®Google Scholar
• Jurasz P, Alonso D, Castro-Blanco S, Murad F, Radomski MW. Generation and role of angiostatin in human platelets. Blood 2003;102:3217–3223
   PubMed Web of Science ®Google Scholar
• Ma L, Perini R, McKnight W, Dicay M, Klein A, Hollenberg MD, Wallace JL. Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets. Proc Natl Acad Sci USA 2005;102:216–220
   PubMed Web of Science ®Google Scholar
• Ikenaka Y, Yoshiji H, Kuriyama S, Yoshii J, Noguchi R, Tsujinoue H, Yanase K, Namisaki T, Imazu H, Masaki T, et al. Tissue inhibitor of metalloproteinases-1 (TIMP-1) inhibits tumor growth and angiogenesis in the TIMP-1 transgenic mouse model. Int J Cancer 2003;105:340–346
   PubMed Web of Science ®Google Scholar
• Italiano JE, Jr., Richardson JL, Patel-Hett S, Battinelli E, Zaslavsky A, Short S, Ryeom S, Folkman J, Klement GL. Angiogenesis is regulated by a novel mechanism: Pro- and anti-angiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood 2008;111:1227–1233
   PubMed Web of Science ®Google Scholar
• Kamykowski J, Carlton P, Sehgal S, Storrie B. Quantitative immunofluorescence mapping reveals little functional coclustering of proteins within platelet alpha-granules. Blood 2011;118:1370–1373
   PubMed Web of Science ®Google Scholar
• van Nispen tot Pannerden H, de Haas F, Geerts W, Posthuma G, van Dijk S, Heijnen HF. The platelet interior revisited: Electron tomography reveals tubular alpha-granule subtypes. Blood 2010;116:1147–1156
   PubMed Web of Science ®Google Scholar
• Jonnalagadda D, Izu LT, Whiteheart SW. Platelet secretion is kinetically heterogeneous in an agonist-responsive manner. Blood 2012;120:5209–5216
   PubMed Web of Science ®Google Scholar
• Horstman LL, Ahn YS. Platelet microparticles: A wide-angle perspective. Crit Rev Oncol Hematol 1999;30:111–142
   PubMed Web of Science ®Google Scholar
• Berckmans RJ, Nieuwland R, Boing AN, Romijn FP, Hack CE, Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001;85:639–646
   PubMed Web of Science ®Google Scholar
• Sims PJ, Wiedmer T, Esmon CT, Weiss HJ, Shattil SJ. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: An isolated defect in platelet procoagulant activity. J Biol Chem 1989;264:17049–17057
   PubMed Web of Science ®Google Scholar
• Italiano JE, Jr Mairuhu AT, Flaumenhaft R. Clinical relevance of microparticles from platelets and megakaryocytes. Curr Opin Hematol 2010;17:578–584
   PubMed Web of Science ®Google Scholar
• Kim HK, Song KS, Park YS, Kang YH, Lee YJ, Lee KR, Kim HK, Ryu KW, Bae JM, Kim S. Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: Possible role of a metastasis predictor. Eur J Cancer 2003;39:184–191
   PubMed Web of Science ®Google Scholar
• Weber A, Koppen HO, Schror K. Platelet-derived microparticles stimulate coronary artery smooth muscle cell mitogenesis by a PDGF-independent mechanism. Thromb Res 2000;98:461–466
   PubMed Web of Science ®Google Scholar
• Baj-Krzyworzeka M, Majka M, Pratico D, Ratajczak J, Vilaire G, Kijowski J, Reca R, Janowska-Wieczorek A, Ratajczak MZ. Platelet-derived microparticles stimulate proliferation, #survival, |adhesion, and chemotaxis of hematopoietic cells. Exp Hematol 2002;30:450–459
   PubMed Web of Science ®Google Scholar
• Kim HK, Song KS, Chung JH, Lee KR, Lee SN. Platelet microparticles induce angiogenesis in vitro. Br J Haematol 2004;124:376–384
   PubMed Web of Science ®Google Scholar
• Brill A, Dashevsky O, Rivo J, Gozal Y, Varon D. Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization. Cardiovasc Res 2005;67:30–38
   PubMed Web of Science ®Google Scholar
• Hayon Y, Dashevsky O, Shai E, Brill A, Varon D, Leker RR. Platelet microparticles induce angiogenesis and neurogenesis after cerebral ischemia. Curr Neurovasc Res 2012;9:185–192
   PubMedGoogle Scholar
• Janowska-Wieczorek A, Majka M, Kijowski J, Baj-Krzyworzeka M, Reca R, Turner AR, Ratajczak J, Emerson SG, Kowalska MA, Ratajczak MZ. Platelet-derived microparticles bind to hematopoietic stem/progenitor cells and enhance their engraftment. Blood 2001;98:3143–3149
   PubMed Web of Science ®Google Scholar
• Ohtsuka M, Sasaki K, Ueno T, Seki R, Nakayoshi T, Koiwaya H, Toyama Y, Yokoyama S, Mitsutake Y, Chibana H, et al. Platelet-derived microparticles augment the adhesion and neovascularization capacities of circulating angiogenic cells obtained from atherosclerotic patients. Atherosclerosis 2013;227:275–282
   PubMedGoogle Scholar
• Mallat Z, Benamer H, Hugel B, Benessiano J, Steg PG, Freyssinet JM, Tedgui A. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000;101:841–843
   PubMed Web of Science ®Google Scholar
• English D, Garcia JG, Brindley DN. Platelet-released phospholipids link haemostasis and angiogenesis. Cardiovasc Res 2001;49:588–599
   PubMed Web of Science ®Google Scholar
• Beer MS, Stanton JA, Salim K, Rigby M, Heavens RP, Smith D, Mcallister G. EDG receptors as a therapeutic target in the nervous system. Ann N Y Acad Sci 2000;905:118–131
   PubMedGoogle Scholar
• Kluk MJ, Hla T. Role of the sphingosine 1-phosphate receptor EDG-1 in vascular smooth muscle cell proliferation and migration. Circ Res 2001;89:496–502
   PubMed Web of Science ®Google Scholar
• Goetzl EJ, An S. Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate. Faseb J 1998;12:1589–1598
   PubMed Web of Science ®Google Scholar
• Lee MJ, Van Brocklyn JR, Thangada S, Liu CH, Hand AR, Menzeleev R, Spiegel S, Hla T. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science 1998;279:1552–1555
   PubMed Web of Science ®Google Scholar
• Kimura T, Watanabe T, Sato K, Kon J, Tomura H, Tamama K, Kuwabara A, Kanda T, Kobayashi I, Ohta H, et al. Sphingosine 1-phosphate stimulates proliferation and migration of human endothelial cells possibly through the lipid receptors, Edg-1 and Edg-3. Biochem J 2000;348 Pt 1:71–76
   PubMed Web of Science ®Google Scholar
• Lee OH, Kim YM, Lee YM, Moon EJ, Lee DJ, Kim JH, Kim KW, Kwon YG. Sphingosine 1-phosphate induces angiogenesis: Its angiogenic action and signaling mechanism in human umbilical vein endothelial cells. Biochem Biophys Res Commun 1999;264:743–750
   PubMed Web of Science ®Google Scholar
• English D, Welch Z, Kovala AT, Harvey K, Volpert OV, Brindley DN, Garcia JG. Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis. Faseb J 2000;14:2255–2265
   PubMed Web of Science ®Google Scholar
• Lee MJ, Thangada S, Claffey KP, Ancellin N, Liu CH, Kluk M, Volpi M, Sha'afi RI, Hla T. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell 1999;99:301–312
   PubMed Web of Science ®Google Scholar
• Yatomi Y, Ruan F, Hakomori S, Igarashi Y. Sphingosine-1-phosphate: A platelet-activating sphingolipid released from agonist-stimulated human platelets. Blood 1995;86:193–202
   PubMed Web of Science ®Google Scholar
• Xiao H, Siddiqui RA, Al-Hassani MH, Sliva D, Kovacs RJ. Phospholipids released from activated platelets improve platelet aggregation and endothelial cell migration. Platelets 2001;12:163–170
   PubMed Web of Science ®Google Scholar
• Watson SP, McConnell RT, Lapetina EG. Decanoyl lysophosphatidic acid induces platelet aggregation through an extracellular action. Evidence against a second messenger role for lysophosphatidic acid. Biochem J 1985;232:61–66
   PubMed Web of Science ®Google Scholar
• Ohmori T, Yatomi Y, Osada M, Ozaki Y. The intracellular action of sphingosine 1-phosphate in GPVI-mediated Ca2 + mobilization in platelets. Thromb Res 2005;115:409–415
   PubMed Web of Science ®Google Scholar
• Ulrych T, Bohm A, Polzin A, Daum G, Nusing RM, Geisslinger G, Hohlfeld T, Schrör K, Rauch BH. Release of sphingosine-1-phosphate from human platelets is dependent on thromboxane formation. J Thromb Haemost 2011;9:790–798
   PubMed Web of Science ®Google Scholar
• Nachman RL, Rafii S. Platelets, petechiae, and preservation of the vascular wall. N Engl J Med 2008;359:1261–1270
   PubMed Web of Science ®Google Scholar
• Ho-Tin-Noe B, Demers M, Wagner DD. How platelets safeguard vascular integrity. J Thromb Haemost 2011;9:56–65
   PubMed Web of Science ®Google Scholar
• Gawaz M, Vogel S. Platelets in tissue repair: Control of apoptosis and interactions with regenerative cells. Blood 2013;122:2550–2554
   PubMed Web of Science ®Google Scholar
• Uhrin P, Zaujec J, Breuss JM, Olcaydu D, Chrenek P, Stockinger H, Fuertbauer E, Moser M, Haiko P, Fässler R, et al. Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation. Blood 2010;115:3997–4005
   PubMed Web of Science ®Google Scholar
• Suzuki-Inoue K, Inoue O, Ding G, Nishimura S, Hokamura K, Eto K, Kashiwagi H, Tomiyama Y, Yatomi Y, Umemura K, et al. Essential in vivo roles of the C-type lectin receptor CLEC-2: Embryonic/neonatal lethality of CLEC-2-deficient mice by blood/lymphatic misconnections and impaired thrombus formation of CLEC-2-deficient platelets. J Biol Chem 2010;285:24494–24507
   PubMed Web of Science ®Google Scholar
• Pepper MS. Lymphangiogenesis and tumor metastasis: Myth or reality? Clin Cancer Res 2001;7:462–468
   PubMed Web of Science ®Google Scholar
• Suzuki-Inoue K, Fuller GL, Garcia A, Eble JA, Pohlmann S, Inoue O, Gartner TK, Hughan SC, Pearce AC, Laing GD, et al. A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2. Blood 2006;107:542–549
   PubMed Web of Science ®Google Scholar
• Suzuki-Inoue K, Kato Y, Inoue O, Kaneko MK, Mishima K, Yatomi Y, Yamazaki Y, Narimatsu H, Ozaki Y. Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells. J Biol Chem 2007;282:25993–26001
   PubMed Web of Science ®Google Scholar
• Watson SP, Herbert JM, Pollitt AY. GPVI and CLEC-2 in hemostasis and vascular integrity. J Thromb Haemost 2010;8:1456–1467
   PubMed Web of Science ®Google Scholar
• Schacht V, Ramirez MI, Hong YK, Hirakawa S, Feng D, Harvey N, Williams M, Dvorak AM, Dvorak HF, Oliver G, Detmar M. T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. Embo J 2003;22:3546–3556
   PubMed Web of Science ®Google Scholar
• Carramolino L, Fuentes J, Garcia-Andres C, Azcoitia V, Riethmacher D, Torres M. Platelets play an essential role in separating the blood and lymphatic vasculatures during embryonic angiogenesis. Circ Res 2010;106:1197–1201
   PubMed Web of Science ®Google Scholar
• Bertozzi CC, Schmaier AA, Mericko P, Hess PR, Zou Z, Chen M, Chen CY, Xu B, Lu MM, Zhou D, et al. Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling. Blood 2010;116:661–670
   PubMed Web of Science ®Google Scholar
• Ross MH, Furth J, Bigelow RR. Changes in cellular composition of the lymph caused by ionizing radiations. Blood 1952;7:417–428
   PubMed Web of Science ®Google Scholar
• Woods MC, Gamble FN, Furth J, Bigelow RR. Control of the postirradiation hemorrhagic state by platelet transfusions. Blood 1953;8:545–553
   PubMed Web of Science ®Google Scholar
• Osada M, Inoue O, Ding G, Shirai T, Ichise H, Hirayama K, Takano K, Yatomi Y, Hirashima M, Fujii H, et al. Platelet activation receptor CLEC-2 regulates blood/lymphatic vessel separation by inhibiting proliferation, migration, and tube formation of lymphatic endothelial cells. J Biol Chem 2012;287:22241–22252
   PubMed Web of Science ®Google Scholar
• Finney BA, Schweighoffer E, Navarro-Nunez L, Benezech C, Barone F, Hughes CE, Langan SA, Lowe KL, Pollitt AY, Mourao-Sa D, et al. CLEC-2 and Syk in the megakaryocytic/platelet lineage are essential for development. Blood 2012;119:1747–1756
   PubMed Web of Science ®Google Scholar
• Osada M, Suzuki-Inoue K, Inoue O, Ozaki Y. [A role of the platelet receptor CLEC-2 in lymphangiogenesis and its clinical application]. Rinsho Byori 2013;61:318–327
   PubMedGoogle Scholar
• Laurens N, Koolwijk P, de Maat MP. Fibrin structure and wound healing. J Thromb Haemost 2006;4:932–939
   PubMed Web of Science ®Google Scholar
• Hoffman M, Harger A, Lenkowski A, Hedner U, Roberts HR, Monroe DM. Cutaneous wound healing is impaired in hemophilia B. Blood 2006;108:3053–3060
   PubMedGoogle Scholar
• Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003;83:835–870
   PubMed Web of Science ®Google Scholar
• Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999;341:738–746
   PubMed Web of Science ®Google Scholar
• Rozman P, Bolta Z. Use of platelet growth factors in treating wounds and soft-tissue injuries. Acta Dermatovenerol Alp Panonica Adriat 2007;16:156–165
   PubMedGoogle Scholar
• Pandya NM, Dhalla NS, Santani DD. Angiogenesis–A new target for future therapy. Vascul Pharmacol 2006;44:265–274
   PubMed Web of Science ®Google Scholar
• Lieberman JR, Daluiski A, Einhorn TA. The role of growth factors in the repair of bone. Biology and clinical applications. J Bone Joint Surg Am 2002;84-A:1032–1044
   PubMed Web of Science ®Google Scholar
• Lynch SE, Nixon JC, Colvin RB, Antoniades HN. Role of platelet-derived growth factor in wound healing: Synergistic effects with other growth factors. Proc Natl Acad Sci USA 1987;84:7696–7700
   PubMed Web of Science ®Google Scholar
• Margolis DJ, Kantor J, Santanna J, Strom BL, Berlin JA. Effectiveness of platelet releasate for the treatment of diabetic neuropathic foot ulcers. Diabetes Care 2001;24:483–488
   PubMed Web of Science ®Google Scholar
• Bhanot S, Alex JC. Current applications of platelet gels in facial plastic surgery. Facial Plast Surg 2002;18:27–33
   PubMedGoogle Scholar
• Sanchez M, Anitua E, Azofra J, Andia I, Padilla S, Mujika I. Comparison of surgically repaired Achilles tendon tears using platelet-rich fibrin matrices. Am J Sports Med 2007;35:245–251
   PubMed Web of Science ®Google Scholar
• Nurden AT, Nurden P, Sanchez M, Andia I, Anitua E. Platelets and wound healing. Front Biosci 2008;13:3532–3548
   PubMed Web of Science ®Google Scholar
• Ho-Tin-Noe B, Goerge T, Cifuni SM, Duerschmied D, Wagner DD. Platelet granule secretion continuously prevents intratumor hemorrhage. Cancer Res 2008;68:6851–6858
   PubMed Web of Science ®Google Scholar
• Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest 2005;115:3378–3384
   PubMed Web of Science ®Google Scholar
• Milovanovic M, Nilsson E, Jaremo P. Relationships between platelets and inflammatory markers in rheumatoid arthritis. Clin Chim Acta 2004;343:237–240
   PubMed Web of Science ®Google Scholar
• Yamashiro K, Tsujikawa A, Ishida S, Usui T, Kaji Y, Honda Y, Ogura Y, Adamis AP. Platelets accumulate in the diabetic retinal vasculature following endothelial death and suppress blood-retinal barrier breakdown. Am J Pathol 2003;163:253–259
   PubMed Web of Science ®Google Scholar
• Berrettini M, Parise P, Constantini V, Grasselli S, Nenci GG. Platelet activation in psoriasis. Thromb Haemost 1985;53:195–197
   PubMed Web of Science ®Google Scholar
• Ferrara N, Kerbel RS. Angiogenesis as a therapeutic target. Nature 2005;438:967–974
   PubMed Web of Science ®Google Scholar
• Lambrechts D, Storkebaum E, Carmeliet P. VEGF: Necessary to prevent motoneuron degeneration, sufficient to treat ALS? Trends Mol Med 2004;10:275–282
   PubMed Web of Science ®Google Scholar
• Duley L, Henderson-Smart DJ, Knight M, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2004;(1):CD004659
   Google Scholar
• Peterson JE, Zurakowski D, Italiano JE, Jr Michel LV, Fox L, Klement GL, Folkman J. Normal ranges of angiogenesis regulatory proteins in human platelets. Am J Hematol 2010;85:487–493
   PubMed Web of Science ®Google Scholar
• Jorgensen L. The role of platelets in the initial stages of atherosclerosis. J Thromb Haemost 2006;4:1443–1449
   PubMedGoogle Scholar
• Massberg S, Brand K, Gruner S, Page S, Muller E, Muller I, Bergmeier W, Richter T, Lorenz M, Konrad I, et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 2002;196:887–896
   PubMed Web of Science ®Google Scholar
• Nieswandt B, Aktas B, Moers A, Sachs UJ. Platelets in atherothrombosis: Lessons from mouse models. J Thromb Haemost 2005;3:1725–1736
   PubMedGoogle Scholar
• Burger PC, Wagner DD. Platelet P-selectin facilitates atherosclerotic lesion development. Blood 2003;101:2661–2666
   PubMed Web of Science ®Google Scholar
• Methia N, Andre P, Denis CV, Economopoulos M, Wagner DD. Localized reduction of atherosclerosis in von Willebrand factor-deficient mice. Blood 2001;98:1424–1428
   PubMed Web of Science ®Google Scholar
• Gawaz M, Stellos K, Langer HF. Platelets modulate atherogenesis and progression of atherosclerotic plaques via interaction with progenitor and dendritic cells. J Thromb Haemost 2008;6:235–242
   PubMedGoogle Scholar
• Li N. CD4 + T cells in atherosclerosis: Regulation by platelets. Thromb Haemost 2013;109:980–990
   PubMed Web of Science ®Google Scholar
• Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994;331:1480–1487
   PubMed Web of Science ®Google Scholar
• Hammes HP, Lin J, Bretzel RG, Brownlee M, Breier G. Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat. Diabetes 1998;47:401–406
   PubMed Web of Science ®Google Scholar
• Ishibashi T, Tanaka K, Taniguchi Y. Platelet aggregation and coagulation in the pathogenesis of diabetic retinopathy in rats. Diabetes 1981;30:601–606
   PubMedGoogle Scholar
• Simo R, Carrasco E, Garcia-Ramirez M, Hernandez C. Angiogenic and anti-angiogenic factors in proliferative diabetic retinopathy. Curr Diabetes Rev 2006;2:71–98
   PubMedGoogle Scholar
• Folkman J. Tumor angiogenesis: Therapeutic implications. N Engl J Med 1971;285:1182–1186
   PubMed Web of Science ®Google Scholar
• Ringvall M, Thulin A, Zhang L, Cedervall J, Tsuchida-Straeten N, Jahnen-Dechent W, Siegbahn A, Olsson AK. Enhanced platelet activation mediates the accelerated angiogenic switch in mice lacking histidine-rich glycoprotein. PLoS One 2011;6:e14526
   Google Scholar
• Kitchens CS, Weiss L. Ultrastructural changes of endothelium associated with thrombocytopenia. Blood 1975;46:567–578
   PubMed Web of Science ®Google Scholar
• Aird WC. Molecular heterogeneity of tumor endothelium. Cell Tissue Res 2009;335:271–281
   PubMed Web of Science ®Google Scholar
• Jain RK. Determinants of tumor blood flow: A review. Cancer Res 1988;48:2641–2658
   PubMed Web of Science ®Google Scholar
• Ho-Tin-Noe B, Carbo C, Demers M, Cifuni SM, Goerge T, Wagner DD. Innate immune cells induce hemorrhage in tumors during thrombocytopenia. Am J Pathol 2009;175:1699–1708
   PubMed Web of Science ®Google Scholar
• Manegold PC, Hutter J, Pahernik SA, Messmer K, Dellian M. Platelet-endothelial interaction in tumor angiogenesis and microcirculation. Blood 2003;101:1970–1976
   PubMed Web of Science ®Google Scholar
• Nieswandt B, Hafner M, Echtenacher B, Mannel DN. Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res 1999;59:1295–1300
   PubMed Web of Science ®Google Scholar
• Palumbo JS, Talmage KE, Massari JV, La Jeunesse CM, Flick MJ, Kombrinck KW, Jirousková M, Degen JL. Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood 2005;105:178–185
   PubMed Web of Science ®Google Scholar
• Kopp HG, Placke T, Salih HR. Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity. Cancer Res 2009;69:7775–7783
   PubMed Web of Science ®Google Scholar
• Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell 2011;20:576–590
   PubMed Web of Science ®Google Scholar
• Hall CL, Dubyk CW, Riesenberger TA, Shein D, Keller ET, van Golen KL. Type I collagen receptor (alpha2beta1) signaling promotes prostate cancer invasion through RhoC GTPase. Neoplasia 2008;10:797–803
   Web of Science ®Google Scholar
• Chen YQ, Trikha M, Gao X, Bazaz R, Porter AT, Timar J, Honn KV. Ectopic expression of platelet integrin alphaIIb beta3 in tumor cells from various species and histological origin. Int J Cancer 1997;72:642–648
   PubMedGoogle Scholar
• Gasic GJ. Role of plasma, platelets, and endothelial cells in tumor metastasis. Cancer Metastasis Rev 1984;3:99–114
   PubMed Web of Science ®Google Scholar
• Amirkhosravi A, Mousa SA, Amaya M, Blaydes S, Desai H, Meyer T, Francis JL. Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb/IIIa antagonist XV454. Thromb Haemost 2003;90:549–554
   PubMed Web of Science ®Google Scholar
• Jain S, Zuka M, Liu J, Russell S, Dent J, Guerrero JA, Forsyth J, Maruszak B, Gartner TK, Felding-Habermann B, Ware J. Platelet glycoprotein Ib alpha supports experimental lung metastasis. Proc Natl Acad Sci USA 2007;104:9024–9028
   PubMedGoogle Scholar
• Jain S, Russell S, Ware J. Platelet glycoprotein VI facilitates experimental lung metastasis in syngenic mouse models. J Thromb Haemost 2009;7:1713–1717
   PubMedGoogle Scholar
• Ludwig RJ, Boehme B, Podda M, Henschler R, Jager E, Tandi C, Boehncke WH, Zollner TM, Kaufmann R, Gille J. Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis. Cancer Res 2004;64:2743–2750
   PubMed Web of Science ®Google Scholar
• Karpatkin S, Ambrogio C, Pearlstein E. The role of tumor-induced platelet aggregation, platelet adhesion and adhesive proteins in tumor metastasis. Prog Clin Biol Res 1988;283:585–606
   PubMedGoogle Scholar
• Erpenbeck L, Nieswandt B, Schon M, Pozgajova M, Schon MP. Inhibition of platelet GPIb alpha and promotion of melanoma metastasis. J Invest Dermatol 2010;130:576–586
   PubMedGoogle Scholar
• Borsig L. The role of platelet activation in tumor metastasis. Expert Rev Anticancer Ther 2008;8:1247–1255
   PubMed Web of Science ®Google Scholar
• Erpenbeck L, Schon MP. Deadly allies: The fatal interplay between platelets and metastasizing cancer cells. Blood 2010;115:3427–3436
   PubMed Web of Science ®Google Scholar
• Jain S, Harris J, Ware J. Platelets: Linking hemostasis and cancer. Arterioscler Thromb Vasc Biol 2010;30:2362–2367
   PubMed Web of Science ®Google Scholar
• Coupland LA, Chong BH, Parish CR. Platelets and p-selectin control tumor cell metastasis in an organ-specific manner and independently of NK cells. Cancer Res 2012;72:4662–4671
   PubMedGoogle Scholar
• Schumacher D, Strilic B, Sivaraj KK, Wettschureck N, Offermanns S. Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor. Cancer Cell 2013;24:130–137
   PubMed Web of Science ®Google Scholar
• Kerr BA, McCabe NP, Feng W, Byzova TV. Platelets govern pre-metastatic tumor communication to bone. Oncogene 2013;32:4319–4324
   PubMedGoogle Scholar
• Zhang W, Dang S, Hong T, Tang J, Fan J, Bu D, Sun Y, Wang Z, Wisniewski T. A humanized single-chain antibody against beta 3 integrin inhibits pulmonary metastasis by preferentially fragmenting activated platelets in the tumor microenvironment. Blood 2012;120:2889–2898
   PubMed Web of Science ®Google Scholar
• Egan K, Crowley D, Smyth P, O'Toole S, Spillane C, Martin C, Gallagher M, Canney A, Norris L, Conlon N, et al. Platelet adhesion and degranulation induce pro-survival and pro-angiogenic signalling in ovarian cancer cells. PLoS One 2011;6:e26125
   Web of Science ®Google Scholar
• Amirkhosravi A, Amaya M, Siddiqui F, Biggerstaff JP, Meyer TV, Francis JL. Blockade of GpIIb/IIIa inhibits the release of vascular endothelial growth factor (VEGF) from tumor cell-activated platelets and experimental metastasis. Platelets 1999;10:285–292
   PubMed Web of Science ®Google Scholar
• Engebraaten O, Trikha M, Juell S, Garman-Vik S, Fodstad O. Inhibition of in vivo tumour growth by the blocking of host alpha(v)beta3 and alphaII(b)beta3 integrins. Anticancer Res 2009;29:131–137
   PubMedGoogle Scholar
• Battinelli EM, Markens BA, Italiano JE Jr. Release of angiogenesis regulatory proteins from platelet alpha granules: Modulation of physiologic and pathologic angiogenesis. Blood 2011;118:1359–1369
   PubMed Web of Science ®Google Scholar
• Battinelli EM, Markens BA, Kulenthirarajan RA, Machlus KR, Flaumenhaft R, Italiano JE Jr. Anticoagulation inhibits tumor cell mediated release of platelet angiogenic proteins and diminishes platelet angiogenic response. Blood 2014;123:101–112
   PubMed Web of Science ®Google Scholar
• Bluff JE, Brown NJ, Reed MW, Staton CA. Tissue factor, angiogenesis and tumour progression. Breast Cancer Res 2008;10:204
   PubMed Web of Science ®Google Scholar
• Callander NS, Varki N, Rao LV. Immunohistochemical identification of tissue factor in solid tumors. Cancer 1992;70:1194–1201
   PubMed Web of Science ®Google Scholar
• Mechtcheriakova D, Wlachos A, Holzmuller H, Binder BR, Hofer E. Vascular endothelial cell growth factor-induced tissue factor expression in endothelial cells is mediated by EGR-1. Blood 1999;93:3811–3823
   PubMed Web of Science ®Google Scholar
• Stone RL, Nick AM, McNeish IA, Balkwill F, Han HD, Bottsford-Miller J, Rupairmoole R, Armaiz-Pena GN, Pecot CV, Coward J, et al. Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med 2012;366:610–618
   PubMed Web of Science ®Google Scholar
• Salgado R, Vermeulen PB, Benoy I, Weytjens R, Huget P, Van Marck E, Dirix LY. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients. Br J Cancer 1999;80:892–897
   PubMed Web of Science ®Google Scholar
• Caine GJ, Lip GY, Blann AD. Platelet-derived VEGF, Flt-1, angiopoietin-1 and P-selectin in breast and prostate cancer: Further evidence for a role of platelets in tumour angiogenesis. Ann Med 2004;36:273–277
   PubMed Web of Science ®Google Scholar
• Salven P, Orpana A, Joensuu H. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor. Clin Cancer Res 1999;5:487–491
   PubMed Web of Science ®Google Scholar
• Gonzalez FJ, Rueda A, Sevilla I, Alonso L, Villarreal V, Torres E, Alba E. Shift in the balance between circulating thrombospondin-1 and vascular endothelial growth factor in cancer patients: Relationship to platelet alpha-granule content and primary activation. Int J Biol Markers 2004;19:221–228
   Web of Science ®Google Scholar
• Helley D, Banu E, Bouziane A, Banu A, Scotte F, Fischer AM, Oudard S. Platelet microparticles: A potential predictive factor of survival in hormone-refractory prostate cancer patients treated with docetaxel-based chemotherapy. Eur Urol 2009;56:479–484
   PubMedGoogle Scholar
• Lip GY, Chin BS, Blann AD. Cancer and the prothrombotic state. Lancet Oncol 2002;3:27–34
   PubMed Web of Science ®Google Scholar
• Fontaine E, McShane J, Page R, Shackcloth M, Mediratta N, Carr M, Soorae A, Poullis M. Aspirin and non-small cell lung cancer resections: Effect on long-term survival. Eur J Cardiothorac Surg 2010;38:21–26
   PubMedGoogle Scholar
• Holmes MD, Chen WY, Li L, Hertzmark E, Spiegelman D, Hankinson SE. Aspirin intake and survival after breast cancer. J Clin Oncol 2010;28:1467–1472
   PubMed Web of Science ®Google Scholar
• Holmes CE, Huang JC, Pace TR, Howard AB, Muss HB. Tamoxifen and aromatase inhibitors differentially affect vascular endothelial growth factor and endostatin levels in women with breast cancer. Clin Cancer Res 2008;14:3070–3076
   PubMed Web of Science ®Google Scholar
• Creagan ET, Twito DI, Johansson SL, Schaid DJ, Johnson PS, Flaum MA, Buroker TR, Geeraerts LH, Veeder MH, Gesme DHJr, et al. A randomized prospective assessment of recombinant leukocyte A human interferon with or without aspirin in advanced renal adenocarcinoma. J Clin Oncol 1991;9:2104–2109
   PubMed Web of Science ®Google Scholar
• Lipton A, Scialla S, Harvey H, Dixon R, Gordon R, Hamilton R, Ramsey H, Weltz M, Heckard R, White D. Adjuvant antiplatelet therapy with aspirin in colo-rectal cancer. J Med 1982;13:419–429
   PubMedGoogle Scholar
• Kakkar AK, Levine MN, Kadziola Z, Lemoine NR, Low V, Patel HK, Rustin G, Thomas M, Quigley M, Williamson RC. Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: The fragmin advanced malignancy outcome study (FAMOUS). J Clin Oncol 2004;22:1944–1948
   PubMed Web of Science ®Google Scholar
• Lemoine NR. Antithrombotic therapy in cancer. J Clin Oncol 2005;23:2119–2120
   PubMedGoogle Scholar
• Nash GF, Walsh DC, Kakkar AK. The role of the coagulation system in tumour angiogenesis. Lancet Oncol 2001;2:608–613
   PubMed Web of Science ®Google Scholar
• Bergers G, Hanahan D. Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer 2008;8:592–603
   PubMed Web of Science ®Google Scholar
• Bridges EM, Harris AL. The angiogenic process as a therapeutic target in cancer. Biochem Pharmacol 2011;81:1183–1191
   PubMed Web of Science ®Google Scholar
• Handsley MM, Edwards DR. Metalloproteinases and their inhibitors in tumor angiogenesis. Int J Cancer 2005;115:849–860
   PubMed Web of Science ®Google Scholar
• Sato N, Beitz JG, Kato J, Yamamoto M, Clark JW, Calabresi P, Raymond A, Frackelton AR Jr. Platelet-derived growth factor indirectly stimulates angiogenesis in vitro. Am J Pathol 1993;142:1119–1130
   PubMed Web of Science ®Google Scholar
• Ueki N, Nakazato M, Ohkawa T, Ikeda T, Amuro Y, Hada T, Higashino K. Excessive production of transforming growth-factor beta 1 can play an important role in the development of tumorigenesis by its action for angiogenesis: Validity of neutralizing antibodies to block tumor growth. Biochim Biophys Acta 1992;1137:189–196
   PubMed Web of Science ®Google Scholar
• Nakamura T, Teramoto H, Ichihara A. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc Natl Acad Sci USA 1986;83:6489–6493
   PubMed Web of Science ®Google Scholar
• Rofstad EK, Halsor EF. Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts. Cancer Res 2000;60:4932–4938
   PubMed Web of Science ®Google Scholar
• Zamani A, Qu Z. Serotonin activates angiogenic phosphorylation signaling in human endothelial cells. FEBS Lett 2012;586:2360–2365
   PubMed Web of Science ®Google Scholar
• Bertrand-Duchesne MP, Grenier D, Gagnon G. Epidermal growth factor released from platelet-rich plasma promotes endothelial cell proliferation in vitro. J Periodontal Res 2010;45:87–93
   PubMed Web of Science ®Google Scholar
• Tashiro Y, Nishida C, Sato-Kusubata K, Ohki-Koizumi M, Ishihara M, Sato A, Gritli I, Komiyama H, Sato Y, Dan T, et al. Inhibition of PAI-1 induces neutrophil-driven neoangiogenesis and promotes tissue regeneration via production of angiocrine factors in mice. Blood 2012;119:6382–6393
   PubMedGoogle Scholar
• Roberts AB, Sporn MB. Regulation of endothelial cell growth, architecture, and matrix synthesis by TGF-beta. Am Rev Respir Dis 1989;140:1126–1128
   PubMed Web of Science ®Google Scholar
• Struyf S, Burdick MD, Proost P, Van Damme J, Strieter RM. Platelets release CXCL4L1, a nonallelic variant of the chemokine platelet factor-4/CXCL4 and potent inhibitor of angiogenesis. Circ Res 2004;95:855–857
   PubMed Web of Science ®Google Scholar